394 related articles for article (PubMed ID: 31744449)
41. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
42. iNOS induction and PARP-1 activation in human atherosclerotic lesions: an immunohistochemical and ultrastructural approach.
Perrotta I; Brunelli E; Sciangula A; Conforti F; Perrotta E; Tripepi S; Donato G; Cassese M
Cardiovasc Pathol; 2011; 20(4):195-203. PubMed ID: 20619687
[TBL] [Abstract][Full Text] [Related]
43. Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr
Zhao L; Cozzo AJ; Johnson AR; Christensen T; Freemerman AJ; Bear JE; Rotty JD; Bennett BJ; Makowski L
Atherosclerosis; 2017 Nov; 266():182-189. PubMed ID: 29035781
[TBL] [Abstract][Full Text] [Related]
44. Ogg1-Dependent DNA Repair Regulates NLRP3 Inflammasome and Prevents Atherosclerosis.
Tumurkhuu G; Shimada K; Dagvadorj J; Crother TR; Zhang W; Luthringer D; Gottlieb RA; Chen S; Arditi M
Circ Res; 2016 Sep; 119(6):e76-90. PubMed ID: 27384322
[TBL] [Abstract][Full Text] [Related]
45. Mitochondrial DNA-LL-37 Complex Promotes Atherosclerosis by Escaping from Autophagic Recognition.
Zhang Z; Meng P; Han Y; Shen C; Li B; Hakim MA; Zhang X; Lu Q; Rong M; Lai R
Immunity; 2015 Dec; 43(6):1137-47. PubMed ID: 26680206
[TBL] [Abstract][Full Text] [Related]
46. P2Y
Jin H; Ko YS; Park SW; Kim HJ
Free Radic Biol Med; 2019 May; 136():109-117. PubMed ID: 30959169
[TBL] [Abstract][Full Text] [Related]
47. Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis.
Manea SA; Vlad ML; Fenyo IM; Lazar AG; Raicu M; Muresian H; Simionescu M; Manea A
Redox Biol; 2020 Jan; 28():101338. PubMed ID: 31634818
[TBL] [Abstract][Full Text] [Related]
48. Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy.
Victor VM; Apostolova N; Herance R; Hernandez-Mijares A; Rocha M
Curr Med Chem; 2009; 16(35):4654-67. PubMed ID: 19903143
[TBL] [Abstract][Full Text] [Related]
49. Relationship between Cellular Oxygen Consumption and Atherosclerosis-Associated Mitochondrial Mutations (Variants of the Mitochondrial Genome).
Orekhov AN; Sinyov VV; Vyssokikh MY; Manukhova L; Marey MV; Angelova PR; Omelchenko AV; Vinokurov AY; Khasanova ZB; Sobenin IA
Curr Med Chem; 2024 Jun; ():. PubMed ID: 38879762
[TBL] [Abstract][Full Text] [Related]
50. Enhanced base excision repair capacity in carotid atherosclerosis may protect nuclear DNA but not mitochondrial DNA.
Skarpengland T; Dahl TB; Skjelland M; Scheffler K; de Sousa MML; Gregersen I; Kuśnierczyk A; Sharma A; Slupphaug G; Eide L; Segers FM; Skagen KR; Dahl CP; Russell D; Folkersen L; Krohg-Sørensen K; Holm S; Bjørås M; Aukrust P; Halvorsen B
Free Radic Biol Med; 2016 Aug; 97():386-397. PubMed ID: 27381496
[TBL] [Abstract][Full Text] [Related]
51. The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques.
Rai V; Agrawal DK
Can J Physiol Pharmacol; 2017 Oct; 95(10):1245-1253. PubMed ID: 28746820
[TBL] [Abstract][Full Text] [Related]
52. Melatonin and its atheroprotective effects: a review.
Favero G; Rodella LF; Reiter RJ; Rezzani R
Mol Cell Endocrinol; 2014 Feb; 382(2):926-37. PubMed ID: 24291636
[TBL] [Abstract][Full Text] [Related]
53. New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis.
Wu MY; Li CJ; Hou MF; Chu PY
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937652
[TBL] [Abstract][Full Text] [Related]
54. The Characteristics and Roles of Advanced Oxidation Protein Products in Atherosclerosis.
Ou H; Huang Z; Mo Z; Xiao J
Cardiovasc Toxicol; 2017 Jan; 17(1):1-12. PubMed ID: 27350146
[TBL] [Abstract][Full Text] [Related]
55. Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis.
Mallavia B; Recio C; Oguiza A; Ortiz-Muñoz G; Lazaro I; Lopez-Parra V; Lopez-Franco O; Schindler S; Depping R; Egido J; Gomez-Guerrero C
Am J Pathol; 2013 May; 182(5):1910-21. PubMed ID: 23597852
[TBL] [Abstract][Full Text] [Related]
56. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
[TBL] [Abstract][Full Text] [Related]
57. [Analysis of Heteroplasmy in the Major Noncoding Region of Mitochondrial DNA in the Blood and Atherosclerotic Plaques of Carotid Arteries].
Golubenko MV; Nazarenko MS; Frolov AV; Sleptsov AA; Markov AV; Glushkova ME; Barbarash OL; Puzyrev VP
Genetika; 2016 Apr; 52(4):497-502. PubMed ID: 27529986
[TBL] [Abstract][Full Text] [Related]
58. LncRNA-modulated autophagy in plaque cells: a new paradigm of gene regulation in atherosclerosis?
Ren K; Xu XD; Yu XH; Li MQ; Shi MW; Liu QX; Jiang T; Zheng XL; Yin K; Zhao GJ
Aging (Albany NY); 2020 Nov; 12(21):22335-22349. PubMed ID: 33154191
[TBL] [Abstract][Full Text] [Related]
59. Role of mitochondria in oxidative stress and ageing.
Lenaz G
Biochim Biophys Acta; 1998 Aug; 1366(1-2):53-67. PubMed ID: 9714734
[TBL] [Abstract][Full Text] [Related]
60. Low Cytochrome Oxidase 1 Links Mitochondrial Dysfunction to Atherosclerosis in Mice and Pigs.
Holvoet P; Vanhaverbeke M; Geeraert B; De Keyzer D; Hulsmans M; Janssens S
PLoS One; 2017; 12(1):e0170307. PubMed ID: 28122051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
